ARENA, UMBERTO
 Distribuzione geografica
Continente #
NA - Nord America 2.084
EU - Europa 1.513
AS - Asia 1.161
SA - Sud America 189
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 42
OC - Oceania 14
Totale 5.051
Nazione #
US - Stati Uniti d'America 2.039
RU - Federazione Russa 463
IT - Italia 340
SG - Singapore 303
CN - Cina 302
PL - Polonia 278
BR - Brasile 152
HK - Hong Kong 149
VN - Vietnam 129
IE - Irlanda 95
KR - Corea 89
SE - Svezia 83
FI - Finlandia 66
DE - Germania 58
FR - Francia 49
IN - India 42
BD - Bangladesh 40
JO - Giordania 39
GB - Regno Unito 31
CA - Canada 29
NL - Olanda 22
JP - Giappone 20
ID - Indonesia 14
AU - Australia 13
AR - Argentina 12
EG - Egitto 10
ES - Italia 9
ZA - Sudafrica 9
MX - Messico 7
PE - Perù 7
UZ - Uzbekistan 7
DZ - Algeria 5
NG - Nigeria 5
DK - Danimarca 4
MA - Marocco 4
NP - Nepal 4
PH - Filippine 4
UY - Uruguay 4
VE - Venezuela 4
CL - Cile 3
IQ - Iraq 3
PK - Pakistan 3
PY - Paraguay 3
AL - Albania 2
BG - Bulgaria 2
BJ - Benin 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EC - Ecuador 2
KG - Kirghizistan 2
SA - Arabia Saudita 2
SV - El Salvador 2
TG - Togo 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CO - Colombia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 5.003
Città #
Santa Clara 450
Ashburn 305
Warsaw 274
Singapore 211
Fairfield 151
Hong Kong 128
San Jose 100
Dublin 94
Seoul 87
Chandler 74
Hefei 74
Woodbridge 61
Beijing 53
Los Angeles 53
Houston 52
Ho Chi Minh City 49
Milan 49
Helsinki 48
Seattle 47
Cambridge 46
Florence 42
Council Bluffs 39
Wilmington 39
São Paulo 33
Rome 31
New York 29
Buffalo 28
Hanoi 28
Altamura 26
Lawrence 26
Munich 25
Lauterbourg 23
Mumbai 18
Princeton 18
Ann Arbor 17
Dallas 16
Moscow 15
Boston 13
Naples 13
Phoenix 13
Shanghai 13
The Dalles 12
Melbourne 11
Boardman 10
Jakarta 10
London 10
Paris 10
Sapporo 10
Clifton 9
Frankfurt am Main 9
Kent 9
Tokyo 9
City of London 8
Turku 8
Bremen 7
Cairo 7
Lappeenranta 7
Venice 7
Bologna 6
Rio de Janeiro 6
Riverside 6
Shenzhen 6
Toronto 6
Turin 6
Atlanta 5
Brooklyn 5
Chicago 5
Fano 5
Figino 5
Medford 5
Montreal 5
San Francisco 5
Abuja 4
Almere Stad 4
Barcelona 4
Bengaluru 4
Bexley 4
Catania 4
Dong Ket 4
Falls Church 4
Grandate 4
Guangzhou 4
Lima 4
Miano 4
Parma 4
Porto Alegre 4
Redondo Beach 4
San Diego 4
Tashkent 4
Amman 3
Bari 3
Can Tho 3
Chongqing 3
Columbus 3
Da Nang 3
Haiphong 3
Hillsboro 3
Johannesburg 3
Kalundborg 3
Manaus 3
Totale 3.241
Nome #
Acute on chronic liver failure: From pathophysiology to clinical management. 349
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 315
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 273
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 248
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 237
A large rheumatoid nodule mimicking hepatic malignancy 226
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 223
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 214
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 209
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 202
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 193
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 192
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 178
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 169
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms 168
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 166
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 164
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 162
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 160
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 149
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution? 144
Time-varying mHAP III is the most accurate predictor of survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 136
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life 129
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial 126
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter 125
Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 109
Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPS 85
Totale 5.051
Categoria #
all - tutte 13.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 0 11 4 1 4 8 6 11 9 22 33
2022/2023417 28 72 29 18 32 70 50 36 59 2 15 6
2023/2024179 6 18 26 7 14 33 7 26 5 13 11 13
2024/20251.410 60 126 78 208 335 211 26 82 86 35 54 109
2025/20261.919 223 280 195 152 175 78 219 100 115 128 79 175
2026/2027223 60 76 87 0 0 0 0 0 0 0 0 0
Totale 5.051